title: Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
authors: Maternal Mental Health Program and Department of Clinical Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York (Spinelli) Department of Psychiatry, Baylor College of Medicine, Houston, Texas, and Postpartum Support International, Portland, Oregon (Puryear) The Motherisk Program, The Hospital for Sick Children, Toronto, Canada (Einarson).
authors: Margaret
authors: M
authors: Spinelli
authors: Lucy J
authors: LJ
authors: Puryear
authors: Adrienne
authors: A
authors: Einarson
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology*; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects*; D011247:Pregnancy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
chemical_list: D005473:Fluoxetine; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors